Trial Information
Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia
Inclusion Criteria:
- patients with core binding factor positive acute myeloid leukemia
- 18 years or older
- patients were treated with standard chemotherapy
- patients with available medical record and stored bone marrow specimen at time of
diagnosis
Exclusion Criteria:
- no definitive criteria
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Outcome Measure:
response rate
Outcome Time Frame:
within 1 month after enrollment
Safety Issue:
No
Principal Investigator
Dong Hwan Kim, M.D.,Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Division of Hematology and Oncology/Samsung Medical Center
Authority:
South Korea: Institutional Review Board
Study ID:
2009-06-060
NCT ID:
NCT01079507
Start Date:
February 2010
Completion Date:
Related Keywords:
- Acute Lymphoblastic Leukemia
- single nucleotide polymorphism
- adult acute lymphoblastic leukemia
- Leukemia
- Leukemia, Lymphoid
- Precursor Cell Lymphoblastic Leukemia-Lymphoma